Arbutus Biopharma Sets Date for Q1 2024 Financial Results
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) announced plans to unveil its first quarter financial results for 2024 on Thursday, May 2.
Arbutus Biopharma Sets Date for Q1 2024 Financial Results Read More